ReSTOR Natural +3.0D Study In Japan

Alcon

Status: Completed

Conditions: Cataract

Treatments: Device: ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1

Study type: Interventional

Funder types: Industry

Identifiers

NCT00758576

C-07-44

Details and patient eligibility

About

The objective of this study is to evaluate safety and effectiveness of ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 when implanted to replace the natural lens following cataract removal.

Enrollment: 64 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned bilateral cataract removal by phacoemulsification
• Potential postoperative best corrected visual acuity of 0.5 or over
• 1.5 Diopter (D) or less of astigmatism preoperatively, measured by keratometry

Exclusion criteria

• Poorly controlled glaucoma
• Progressive diabetic retinopathy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

64 participants in 1 patient group

SN6AD1

Experimental group

Description:

AcrySof ReSTOR Model SN6AD1 Intraocular Lens

Treatment:

Device: ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1